Literature DB >> 22974026

Rethinking clinical risk for DNA sequencing.

Thomas May1.   

Abstract

Mesh：

Year:  2012        PMID： 22974026     DOI： 10.1080/15265161.2012.699152

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  2 in total

1.  The limits of traditional approaches to informed consent for genomic medicine.

Authors:  Thomas May; Kaija L Zusevics; Arthur Derse; Kimberly A Strong; Jessica Jeruzal; Alison La Pean Kirschner; Michael H Farrell; Ryan Spellecy
Journal:  HEC Forum       Date:  2014-09

Review 2.  Genome sequencing in the clinic: the past, present, and future of genomic medicine.

Authors:  Jeremy W Prokop; Thomas May; Kim Strong; Stephanie M Bilinovich; Caleb Bupp; Surender Rajasekaran; Elizabeth A Worthey; Jozef Lazar
Journal:  Physiol Genomics       Date:  2018-05-04       Impact factor: 3.107
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.